Colorectal Cancer Coalition

Representative Kathy Dahlkemper Introduces Resolution Regarding Women and Colorectal Cancer

Representative Kathy Dahlkemper (D-PA), recently introduced a resolution regarding women and colon cancer (H.Res. 1053).  Also known as colorectal cancer, colon cancer is the third most commonly diagnosed cancer and the second leading cause of cancer deaths.

Colorectal cancer affects both men and women, and Representative Dahlkemper’s resolution helps to dispel the myth that this disease affects only men by explaining the impact of the disease on women in the United States.  Nearly 55,000 of the new cases of colorectal cancer in the U.S. this year will occur in women, and nearly 25,000 Americans who will die from colorectal cancer in the U.S. this year will be women.

When diagnosed at an early stage, colorectal cancer has a five-year survival rate of 90 percent, but when diagnosed late, the five-year survival rate drops to only 10 percent.  Representative Dahlkemper’s resolution encourages women to regularly undergo screening for colorectal cancer as recommended by their doctors.

As we head into Colorectal Cancer Awareness Month, it is important to remember the impact this disease has on so many Americans and C3 applauds Representative Dahlkemper for introducing a resolution regarding the impact of colorectal cancer on women.

This news article was originally posted on February 24th, 2010 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Catherine Knowles on February 24th, 2010
Tags: Colorectal Cancer Awareness Month, Representative Dahlkemper, Women

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Name Email (hidden) URL Comments (Basic HTML is allowed - a href, strong, em, blockquote)